Bone Biologics
BBLG----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Bone Biologics(BBLG) predict that the EBIT is -805.05 K (--%), Miss estimate;the EPS is -0.43 (--%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBITMiss expectations
-0.00B--
-0.00B--
-0.00B--%
EPSExceed expectations
-0.43--
-0.54--
+0.1100--%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf